Jianyang Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jianyang Zeng has a total of 395 co-authors. Here are the top co-authors by number of shared publications:
- Dan Zhao
Tsinghua University
25 shared publications Shuya Li
School of Engineering, Westlake University, Hangzhou, China
19 shared publicationsYipin Lei
Institute for Interdisciplinary Information Sciences, Tsinghua University
12 shared publicationsFangping Wan
Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, Penn Institute for Computational Science, University of Pennsylvania, Philadelphia, PA 19104, USA
11 shared publications- Han Li
School of Mathematical Sciences and LPMC, Nankai University, Tianjin, China
9 shared publications Sai Zhang
Institute for Interdisciplinary Information Sciences, Tsinghua University, Beijing 100084, China
9 shared publications
Latest Publications
- Top Cited Papers
- 1 July 2026
- Published by Springer Nature in Nature
- Vol. 655 (8121) , 59-70
Towards the construction of a virtual yeast
To advance the computational simulation of cellular life, we propose a virtual yeast, an artificial intelligence (AI)-driven agent that models eukaryotic cellular behaviours by integrating multimodal biological data, mechanistic reasoning and active experimentation using Saccharomyces cerevisiae as a genetically tractable and data-rich model system. Cellular complexity is decomposed into eight function-centred modules, spanning genetic, metabolic and structural systems, each realized as a domain-specific AI tool coordinated through a large language model-based orchestration layer. Built on three data pillars, namely, mechanistic knowledge, subcellular architecture and dynamic states, the system integrates representation learning and generative modelling within a closed-loop learning pipeline that autonomously designs and executes experiments. The virtual yeast serves as both a conceptual and an operational platform to optimize biosynthetic pathways, support the generation and prioritization of hypotheses across diverse cellular processes, and accelerate target discovery. By coupling biological realism with autonomous AI reasoning, the virtual yeast establishes a generalizable blueprint for constructing virtual eukaryotic cells and advancing synthetic biology.
- 1 July 2026
- Published by Springer Nature in Nature
- Vol. 655 (8121) , 59-70
Top Cited PapersTowards the construction of a virtual yeast
To advance the computational simulation of cellular life, we propose a virtual yeast, an artificial intelligence (AI)-driven agent that models eukaryotic cellular behaviours by integrating multimodal biological data, mechanistic reasoning and active experimentation using Saccharomyces cerevisiae as a genetically tractable and data-rich model system. Cellular complexity is decomposed into eight function-centred modules, spanning genetic, metabolic and structural systems, each realized as a domain-specific AI tool coordinated through a large language model-based orchestration layer. Built on three data pillars, namely, mechanistic knowledge, subcellular architecture and dynamic states, the system integrates representation learning and generative modelling within a closed-loop learning pipeline that autonomously designs and executes experiments. The virtual yeast serves as both a conceptual and an operational platform to optimize biosynthetic pathways, support the generation and prioritization of hypotheses across diverse cellular processes, and accelerate target discovery. By coupling biological realism with autonomous AI reasoning, the virtual yeast establishes a generalizable blueprint for constructing virtual eukaryotic cells and advancing synthetic biology.
- Open Access
- 25 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Atlas of predicted protein complex structures across kingdoms
Protein complexes are fundamental to all biological processes. Public repositories have expanded to include millions of potential protein–protein interactions (PPIs) from human and diverse model organisms. Yet, large-scale structural characterization of these complexes—especially across different biological kingdoms—has lagged far behind, leaving most potential and unidentified interactions unresolved. Here, we present a comprehensive atlas of 1.1 million predicted protein–protein interaction structures generated with the AlphaFold2-based ColabFold framework. This dataset spans proteome-wide interactions from bacteria, archaea, humans, mice, plants, and human–virus pairs. Overall, we identify 181,671 high-confidence protein complex structures, especially 37,855 in the human interactome. Structural clustering revealed numerous conserved protein complex architectures shared across kingdoms, providing insights into previously uncharacterized biological functions. Supported by co-immunoprecipitation experiments, we further identify candidate viral receptors for Human mastadenovirus A and Papiine alphaherpesvirus 2. Comparative analyses integrating our complex structures with the AlphaFold monomeric structure database uncovered widespread gene fusion and fission events during evolution. Finally, we demonstrate how our dataset can enhance protein binding–surface prediction using deep learning approaches, illustrating its broad utility beyond structural modeling alone. Altogether, this atlas to our knowledge, represents one of the most extensive cross-kingdom resources and opens avenues for future discoveries in various biomedical applications.
- 25 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessAtlas of predicted protein complex structures across kingdoms
Protein complexes are fundamental to all biological processes. Public repositories have expanded to include millions of potential protein–protein interactions (PPIs) from human and diverse model organisms. Yet, large-scale structural characterization of these complexes—especially across different biological kingdoms—has lagged far behind, leaving most potential and unidentified interactions unresolved. Here, we present a comprehensive atlas of 1.1 million predicted protein–protein interaction structures generated with the AlphaFold2-based ColabFold framework. This dataset spans proteome-wide interactions from bacteria, archaea, humans, mice, plants, and human–virus pairs. Overall, we identify 181,671 high-confidence protein complex structures, especially 37,855 in the human interactome. Structural clustering revealed numerous conserved protein complex architectures shared across kingdoms, providing insights into previously uncharacterized biological functions. Supported by co-immunoprecipitation experiments, we further identify candidate viral receptors for Human mastadenovirus A and Papiine alphaherpesvirus 2. Comparative analyses integrating our complex structures with the AlphaFold monomeric structure database uncovered widespread gene fusion and fission events during evolution. Finally, we demonstrate how our dataset can enhance protein binding–surface prediction using deep learning approaches, illustrating its broad utility beyond structural modeling alone. Altogether, this atlas to our knowledge, represents one of the most extensive cross-kingdom resources and opens avenues for future discoveries in various biomedical applications.
- Open Access
ProMeta: A meta-learning framework for robust disease diagnosis and prediction from plasma proteomics
The plasma proteome offers a dynamic window of human health, capturing the real-time intersections between genetics and physiology. However, the application of deep learning to proteomics is currently hindered by a reliance on large-scale labeled datasets, rendering standard models ineffective for rare or novel diseases where patient samples are inherently scarce. Here, we present ProMeta, a meta-learning framework designed to enable robust disease modeling under extreme data restrictions. By integrating knowledge-guided pathway encoding with bi-level meta-optimization, ProMeta projects unstructured proteomic profiles into biologically interpretable functional tokens. This architecture allows the model to learn a global initialization containing transferable biological priors from biobank-scale data, facilitating rapid adaptation to novel tasks. Through comprehensive benchmark experiments, ProMeta consistently outperformed transfer learning and traditional machine learning baselines in both disease diagnosis and prediction tasks. In the most challenging 4-shot scenarios (utilizing only 2 cases and 2 controls), the model achieved robust generalization with an average AUROC of ∼ 0.69, representing a 24.6% relative improvement over the best-performing baseline methods. Mechanistic investigation revealed that ProMeta disentangles cases from controls in the latent space prior to task-specific adaptation, confirming the acquisition of universal biological rules rather than rote memorization. Furthermore, gradient-based interpretation identified disease-specific protein biomarkers and functional pathways consistent with known pathophysiology. Collectively, ProMeta overcomes the data-scarcity bottleneck in precision medicine, providing a scalable, interpretable framework for characterizing the full spectrum of human diseases, particularly for rare conditions lacking extensive clinical cohorts.
Open AccessProMeta: A meta-learning framework for robust disease diagnosis and prediction from plasma proteomics
The plasma proteome offers a dynamic window of human health, capturing the real-time intersections between genetics and physiology. However, the application of deep learning to proteomics is currently hindered by a reliance on large-scale labeled datasets, rendering standard models ineffective for rare or novel diseases where patient samples are inherently scarce. Here, we present ProMeta, a meta-learning framework designed to enable robust disease modeling under extreme data restrictions. By integrating knowledge-guided pathway encoding with bi-level meta-optimization, ProMeta projects unstructured proteomic profiles into biologically interpretable functional tokens. This architecture allows the model to learn a global initialization containing transferable biological priors from biobank-scale data, facilitating rapid adaptation to novel tasks. Through comprehensive benchmark experiments, ProMeta consistently outperformed transfer learning and traditional machine learning baselines in both disease diagnosis and prediction tasks. In the most challenging 4-shot scenarios (utilizing only 2 cases and 2 controls), the model achieved robust generalization with an average AUROC of ∼ 0.69, representing a 24.6% relative improvement over the best-performing baseline methods. Mechanistic investigation revealed that ProMeta disentangles cases from controls in the latent space prior to task-specific adaptation, confirming the acquisition of universal biological rules rather than rote memorization. Furthermore, gradient-based interpretation identified disease-specific protein biomarkers and functional pathways consistent with known pathophysiology. Collectively, ProMeta overcomes the data-scarcity bottleneck in precision medicine, providing a scalable, interpretable framework for characterizing the full spectrum of human diseases, particularly for rare conditions lacking extensive clinical cohorts.
- Open Access
- 19 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10182
High-accuracy protein complex structure modeling based on sequence-derived structure complementarity
In living organisms, proteins perform key functions required for life activities by interacting to form complexes. Determining the protein complex structure is crucial for understanding and mastering biological functions. Although AlphaFold2 makes a revolutionary breakthrough in predicting protein monomeric structures, accurately capturing inter-chain interaction signals and modeling the structures of protein complexes remain a formidable challenge. In this work, we report DeepSCFold, a pipeline for improving protein complex structure modeling. DeepSCFold uses sequence-based deep learning models to predict protein-protein structural similarity and interaction probability, providing a foundation for identifying interaction partners and constructing deep paired multiple-sequence alignments (MSAs) for protein complex structure prediction. Benchmark results show that DeepSCFold significantly increases the accuracy of protein complex structure prediction compared with state-of-the-art methods. For multimer targets from CASP15, DeepSCFold achieves an improvement of 11.6% and 10.3% in TM-score compared to AlphaFold-Multimer and AlphaFold3, respectively. Furthermore, when applied to antibody-antigen complexes from the SAbDab database, DeepSCFold enhances the prediction success rate for antibody-antigen binding interfaces by 24.7% and 12.4% over AlphaFold-Multimer and AlphaFold3, respectively. These results demonstrate that DeepSCFold effectively captures intrinsic and conserved protein-protein interaction patterns through sequence-derived structure-aware information, rather than relying solely on sequence-level co-evolutionary signals.
- 19 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10182
Open AccessHigh-accuracy protein complex structure modeling based on sequence-derived structure complementarity
In living organisms, proteins perform key functions required for life activities by interacting to form complexes. Determining the protein complex structure is crucial for understanding and mastering biological functions. Although AlphaFold2 makes a revolutionary breakthrough in predicting protein monomeric structures, accurately capturing inter-chain interaction signals and modeling the structures of protein complexes remain a formidable challenge. In this work, we report DeepSCFold, a pipeline for improving protein complex structure modeling. DeepSCFold uses sequence-based deep learning models to predict protein-protein structural similarity and interaction probability, providing a foundation for identifying interaction partners and constructing deep paired multiple-sequence alignments (MSAs) for protein complex structure prediction. Benchmark results show that DeepSCFold significantly increases the accuracy of protein complex structure prediction compared with state-of-the-art methods. For multimer targets from CASP15, DeepSCFold achieves an improvement of 11.6% and 10.3% in TM-score compared to AlphaFold-Multimer and AlphaFold3, respectively. Furthermore, when applied to antibody-antigen complexes from the SAbDab database, DeepSCFold enhances the prediction success rate for antibody-antigen binding interfaces by 24.7% and 12.4% over AlphaFold-Multimer and AlphaFold3, respectively. These results demonstrate that DeepSCFold effectively captures intrinsic and conserved protein-protein interaction patterns through sequence-derived structure-aware information, rather than relying solely on sequence-level co-evolutionary signals.
- Open Access
- 25 July 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (5) , 845-861
Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases
Polygenic risk scores (PRSs) predict an individual’s genetic risk for complex diseases, yet their utility in elucidating disease biology remains limited. We introduce scPRS, a graph neural network-based framework that computes single-cell-resolved PRSs by integrating reference single-cell chromatin accessibility profiles. scPRS outperforms traditional PRS approaches in genetic risk prediction, as demonstrated across multiple diseases including type 2 diabetes, hypertrophic cardiomyopathy, Alzheimer disease and severe COVID-19. Beyond risk prediction, scPRS prioritizes disease-critical cells and, when combined with a layered multiomic analysis, links risk variants to gene regulation in a cell-type-specific manner. Applied to these diseases, scPRS fine-maps causal cell types and cell-type-specific variants and genes, demonstrating its ability to bridge genetic risk with cell-specific biology. scPRS provides a unified framework for genetic risk prediction and mechanistic dissection of complex diseases, laying a methodological foundation for single-cell genetics.
- 25 July 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (5) , 845-861
Open AccessSingle-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases
Polygenic risk scores (PRSs) predict an individual’s genetic risk for complex diseases, yet their utility in elucidating disease biology remains limited. We introduce scPRS, a graph neural network-based framework that computes single-cell-resolved PRSs by integrating reference single-cell chromatin accessibility profiles. scPRS outperforms traditional PRS approaches in genetic risk prediction, as demonstrated across multiple diseases including type 2 diabetes, hypertrophic cardiomyopathy, Alzheimer disease and severe COVID-19. Beyond risk prediction, scPRS prioritizes disease-critical cells and, when combined with a layered multiomic analysis, links risk variants to gene regulation in a cell-type-specific manner. Applied to these diseases, scPRS fine-maps causal cell types and cell-type-specific variants and genes, demonstrating its ability to bridge genetic risk with cell-specific biology. scPRS provides a unified framework for genetic risk prediction and mechanistic dissection of complex diseases, laying a methodological foundation for single-cell genetics.
- Open Access
- 19 November 2024
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 35 (1) , 178-187
Modeling gene interactions in polygenic prediction via geometric deep learning
Polygenic risk score (PRS) is a widely used approach for predicting individuals’ genetic risk of complex diseases, playing a pivotal role in advancing precision medicine. Traditional PRS methods, predominantly following a linear structure, often fall short in capturing the intricate relationships between genotype and phenotype. In this study, we present PRS-Net, an interpretable geometric deep learning–based framework that effectively models the nonlinearity of biological systems for enhanced disease prediction and biological discovery. PRS-Net begins by deconvoluting the genome-wide PRS at the single-gene resolution and then explicitly encapsulates gene–gene interactions leveraging a graph neural network (GNN) for genetic risk prediction, enabling a systematic characterization of molecular interplay underpinning diseases. An attentive readout module is introduced to facilitate model interpretation. Extensive tests across multiple complex traits and diseases demonstrate the superior prediction performance of PRS-Net compared with a wide range of conventional PRS methods. The interpretability of PRS-Net further enhances the identification of disease-relevant genes and gene programs. PRS-Net provides a potent tool for concurrent genetic risk prediction and biological discovery for complex diseases.
- 19 November 2024
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 35 (1) , 178-187
Open AccessModeling gene interactions in polygenic prediction via geometric deep learning
Polygenic risk score (PRS) is a widely used approach for predicting individuals’ genetic risk of complex diseases, playing a pivotal role in advancing precision medicine. Traditional PRS methods, predominantly following a linear structure, often fall short in capturing the intricate relationships between genotype and phenotype. In this study, we present PRS-Net, an interpretable geometric deep learning–based framework that effectively models the nonlinearity of biological systems for enhanced disease prediction and biological discovery. PRS-Net begins by deconvoluting the genome-wide PRS at the single-gene resolution and then explicitly encapsulates gene–gene interactions leveraging a graph neural network (GNN) for genetic risk prediction, enabling a systematic characterization of molecular interplay underpinning diseases. An attentive readout module is introduced to facilitate model interpretation. Extensive tests across multiple complex traits and diseases demonstrate the superior prediction performance of PRS-Net compared with a wide range of conventional PRS methods. The interpretability of PRS-Net further enhances the identification of disease-relevant genes and gene programs. PRS-Net provides a potent tool for concurrent genetic risk prediction and biological discovery for complex diseases.
- Open Access
- 10 October 2024
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 11 (11)
Revolutionizing biomolecular structure determination with artificial intelligence
Han Li, Yipin Lei, Jianyang Zeng; Modeling all-type biomolecular structures with deep learning approaches, National Science Review, , nwae339, https://doi.
- 10 October 2024
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 11 (11)
Open AccessRevolutionizing biomolecular structure determination with artificial intelligence
Han Li, Yipin Lei, Jianyang Zeng; Modeling all-type biomolecular structures with deep learning approaches, National Science Review, , nwae339, https://doi.
- Open Access
- 29 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (40) , e2405404
From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Accurate prediction of protein‐ligand binding affinities is an essential challenge in structure‐based drug design. Despite recent advances in data‐driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein‐ligand complexes is curated, and Dynaformer, a graph‐based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein‐ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state‐of‐the‐art scoring and ranking power on the CASF‐2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.
- 29 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (40) , e2405404
Open AccessFrom Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Accurate prediction of protein‐ligand binding affinities is an essential challenge in structure‐based drug design. Despite recent advances in data‐driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein‐ligand complexes is curated, and Dynaformer, a graph‐based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein‐ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state‐of‐the‐art scoring and ranking power on the CASF‐2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.
- 24 June 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 21 (6) , 1784-1793
Analyzing Large-Scale Single-Cell RNA-Seq Data Using Coreset
The recent boom in single-cell sequencing technologies provides valuable insights into the transcriptomes of individual cells. Through single-cell data analyses, a number of biological discoveries, such as novel cell types, developmental cell lineage trajectories, and gene regulatory networks, have been uncovered. However, the massive and increasingly accumulated single-cell datasets have also posed a seriously computational and analytical challenge for researchers. To address this issue, one typically applies dimensionality reduction approaches to reduce the large-scale datasets. However, these approaches are generally computationally infeasible for tall matrices. In addition, the downstream data analysis tasks such as clustering still take a large time complexity even on the dimension-reduced datasets. We present single-cell Coreset (scCoreset), a data summarization framework that extracts a small weighted subset of cells from a huge sparse single-cell RNA-seq data to facilitate the downstream data analysis tasks. Single-cell data analyses run on the extracted subset yield similar results to those derived from the original uncompressed data. Tests on various single-cell datasets show that scCoreset outperforms the existing data summarization approaches for common downstream tasks such as visualization and clustering. We believe that scCoreset can serve as a useful plug-in tool to improve the efficiency of current single-cell RNA-seq data analyses.
- 24 June 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 21 (6) , 1784-1793
Analyzing Large-Scale Single-Cell RNA-Seq Data Using Coreset
The recent boom in single-cell sequencing technologies provides valuable insights into the transcriptomes of individual cells. Through single-cell data analyses, a number of biological discoveries, such as novel cell types, developmental cell lineage trajectories, and gene regulatory networks, have been uncovered. However, the massive and increasingly accumulated single-cell datasets have also posed a seriously computational and analytical challenge for researchers. To address this issue, one typically applies dimensionality reduction approaches to reduce the large-scale datasets. However, these approaches are generally computationally infeasible for tall matrices. In addition, the downstream data analysis tasks such as clustering still take a large time complexity even on the dimension-reduced datasets. We present single-cell Coreset (scCoreset), a data summarization framework that extracts a small weighted subset of cells from a huge sparse single-cell RNA-seq data to facilitate the downstream data analysis tasks. Single-cell data analyses run on the extracted subset yield similar results to those derived from the original uncompressed data. Tests on various single-cell datasets show that scCoreset outperforms the existing data summarization approaches for common downstream tasks such as visualization and clustering. We believe that scCoreset can serve as a useful plug-in tool to improve the efficiency of current single-cell RNA-seq data analyses.